Loading...
XSHE
002020
Market cap2.19bUSD
Dec 05, Last price  
19.08CNY
1D
-0.21%
1Q
-7.65%
Jan 2017
102.26%
IPO
815.84%
Name

Zhejiang Jingxin Pharmaceutical Co Ltd

Chart & Performance

D1W1MN
XSHE:002020 chart
P/E
21.79
P/S
3.73
EPS
0.88
Div Yield, %
1.57%
Shrs. gr., 5y
1.04%
Rev. gr., 5y
2.66%
Revenues
4.16b
+3.99%
301,881,236428,869,301565,217,329510,305,555531,474,251631,018,882709,730,813857,582,263974,427,3751,235,496,1451,415,696,3561,875,460,9152,219,065,9702,943,801,9953,646,683,9053,258,075,4813,335,970,8893,779,846,2853,998,835,2194,158,550,673
Net income
712m
+15.04%
18,454,70710,491,2241,503,80603,752,63212,895,45829,119,50831,679,04064,348,188107,080,366165,210,090211,946,309264,376,949370,036,653520,396,181653,070,206612,541,758662,253,823618,898,033711,961,458
CFO
726m
-11.95%
61,820,1390029,983,689135,379,70659,548,10469,412,86860,276,649111,031,750210,488,270144,692,818252,694,495385,007,181523,403,340535,301,257513,210,535365,024,284855,777,798824,691,928726,161,370
Dividend
May 24, 20240.3 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Zhejiang Jingxin Pharmaceutical Co., Ltd. researches and develops, produces, and sells pharmaceutical products in China. The company offers APIs, antihypertensive products, antibiotics, quinolones, gastrointestinal promotions, antidiabetics, antipileptics, antihistamines, H+ pump depressants, antihyper cholesterolemia products, histamine H2 receptor blokades, antihyper cholesterolemirs, antidepressants, cephalosporin products, and biopharma products. It also provides diagnostic medical displays, surgical medical displays, clinical medical displays, medical large screens, medical integrated machines, ultrasonic medical displays, and other products. The company was formerly known as Zhejiang Jingxin Pharmaceutical Factory and changed its name to Zhejiang Jingxin Pharmaceutical Co., Ltd. in 2000. Zhejiang Jingxin Pharmaceutical Co., Ltd. was founded in 1974 and is headquartered in Xinchang, China.
URL
https://www.jingxinpharm.com/
IPO date
Jul 15, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT